(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BEPZIFTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BEPZIFTA

ST13

US500000097545143

Class

5

Filing

97545143

Registration

7877428

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

08/05/2025

Trademark type

Word

Nice classes

5

Filing date

08/11/2022

Registration date

08/05/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/05/2025

Last transaction

08/05/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Stevenage, GB

Examiner

OSGOOD, KRYSTINA

Law office

N30

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

Glaxo Group Limited

Representatives

Elizabeth K. Rucki GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseasespaininflammationobesity and cognitive disorders; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalrespiratoryneurologicalgastrointestinaldermatologicalpsychiatric and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/05/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

07/15/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/15/2025

RGIA

REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED

07/15/2025

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

07/09/2025

ABN6

ABANDONMENT - NO USE STATEMENT FILED

07/09/2025

RGIA

REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED

06/13/2025

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

06/09/2025

ABN6

ABANDONMENT - NO USE STATEMENT FILED

06/09/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/05/2024

EX1G

SOU EXTENSION 1 GRANTED

11/05/2024

EXT1

SOU EXTENSION 1 FILED

11/05/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/05/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/07/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/12/2024

PUBO

PUBLISHED FOR OPPOSITION

03/12/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/21/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

01/12/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/29/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/12/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/12/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/12/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/02/2023

GNSL

LETTER OF SUSPENSION E-MAILED

06/02/2023

CNSL

SUSPENSION LETTER WRITTEN

06/02/2023

DOCK

ASSIGNED TO EXAMINER

05/30/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/31/2022

NWAP

NEW APPLICATION ENTERED

08/15/2022

Continuous trademark protection

Get notified about every new filing that threatens BEPZIFTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.